GO
Loading...

Celgene Corp

More

  • Midday Glance: Biotechnology companies Thursday, 15 Jan 2015 | 1:59 PM ET

    Amgen Inc. fell $2.75 or 1.8 percent, to $152.41. Biogen Idec fell $4.64 or 1.3 percent, to $344.11. Celgene Corp. fell $3.28 or 2.7 percent, to $117.82.

  • Early Glance: Biotechnology companies Thursday, 15 Jan 2015 | 11:00 AM ET

    Amgen Inc. fell $1.45 or. 9 percent, to $153.71. Biogen Idec fell $4.30 or 1.2 percent, to $344.45. Celgene Corp. fell $1.82 or 1.5 percent, to $119.28.

  • Final Glance: Biotechnology companies Wednesday, 14 Jan 2015 | 6:07 PM ET

    Amgen Inc. rose$. 02 or percent, to $155.16. Biogen Idec fell $3.99 or 1.1 percent, to $348.75. Celgene Corp. rose $1.12 or. 9 percent, to $121.10.

  • Midday Glance: Biotechnology companies Wednesday, 14 Jan 2015 | 1:43 PM ET

    Amgen Inc. rose$. 26 or. 2 percent, to $155.40. Biogen Idec fell $1.08 or. 3 percent, to $351.66. Celgene Corp. rose $1.74 or 1.5 percent, to $121.72.

  • Early Glance: Biotechnology companies Wednesday, 14 Jan 2015 | 10:41 AM ET

    Amgen Inc. fell$. 01 or percent, to $155.13. Biogen Idec rose $1.21 or. 3 percent, to $353.95. Celgene Corp. rose$. 61 or. 5 percent, to $120.59.

  • Cramer's bankable Bobs: CEOs leading the way Tuesday, 13 Jan 2015 | 6:29 PM ET
    Bob Iger, chairman and CEO of the Walt Disney Company

    In a volatile environment, Jim Cramer nominates two bankable CEOs who will lead the way. And yes, they are both named Bob.

  • Cramer's bankable CEOs: Disney & Celgene  Tuesday, 13 Jan 2015 | 6:25 PM ET

    Mad Money host Jim Cramer congratulates Disney's CEO Bob Iger and Celgene's CEO Bob Hugin for taking their stocks to all-time highs in Tuesday's market.

  • 11 ways to play biotech Monday, 12 Jan 2015 | 6:59 PM ET

    Traders on CNBC's "Fast Money" outlined their strongest plays in the ever-volatile biotechnology space.

  • Midday movers: SanDisk, Chevron, Google & more Monday, 12 Jan 2015 | 12:42 PM ET

    Some of Monday's midday movers:

  • Celgene CEO: Creating a great future  Monday, 12 Jan 2015 | 11:45 AM ET

    CNBC's Meg Tirrell speaks to Robert Hugin, Celgene chairman & CEO, about the company's ambitious long-term guidance and broad-based drug pipeline.

  • Cramer's 10 lessons learned from 2014 Monday, 5 Jan 2015 | 6:10 PM ET
    Traders on the floor of the New York Stock Exchange.

    On a down day in the market, Jim Cramer thinks this is the perfect time to review the silly preconceptions of 2014.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting new records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • *Initial jobless claims fall for fourth straight week. *Biotech shares rebound after sharp two-day decline; energy falls. NEW YORK, Dec 24- U.S. stocks closed flat in a short session on Wednesday as investors found few reasons to push major indexes to their sixth straight day of gains despite strength in biotechs and bullish labor market data.

  • *Initial jobless claims fall for fourth straight week. *Equity markets close at 1 p.m. in holiday-shortened session. NEW YORK, Dec 24- U.S. stocks edged higher on Wednesday, with the Dow and S&P 500 at records and on track for a sixth straight daily advance as biotech stocks rallied and data pointed to improving economic conditions.

  • *Dow, S&P rise for 5th day, both end at records. NEW YORK, Dec 23- U.S. stocks rose on Tuesday, with the Dow closing above 18,000 for the first time ever and the S&P 500 ending at a record after an unexpectedly strong report on economic growth. The Dow rose as high as 18,069.22 and is up about 175 percent from a 12- year closing low hit on March 9, 2009.

  • NEW YORK, Dec 23- U.S. stocks rose for a fifth straight session on Tuesday, with the Dow climbing above 18,000 for the first time ever after an unexpectedly strong report on economic growth. Both the Dow and S&P 500 hit intraday records, and the S&P is on track for its 51st record close of 2014. The gains pushed the Dow as high as 18,051.14, and the blue-chip index is now up...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • Dec 22- The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount. Express Scripts' move reignited investor concerns that pharmaceutical companies...

  • Cramer’s perfect recipe for a Santa Claus rally Thursday, 18 Dec 2014 | 6:13 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Jim Cramer is seeing some good signs in the economy right now. Could they be the perfect ingredients for a Santa Claus rally?